Kidney Week News Today

Alpine Immune Sciences explores strategic options, potentially selling amid interest from buyers. The Seattle-based firm, with soaring stock up over 400%, evaluates various possibilities.

More news  » Challenges Faced By Oncology Nurses https://polldaddy.com/poll/10020480/ Editorial Board Eucharia Borden, MSW, LCSW, OSW-C Ann J.

– Topline data from ongoing Phase 1/2 trials of INZ-701 in adults with ABCC6 Deficiency and ENPP1 Deficiency expected in early April –– Phase 1 tr...

Apellis Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.73 EPS, expectations were $-0.66. Apellis Pharmaceuticals, Inc.

On February 8, 2024, Baxter International Inc. (NYSE: BAX, $39.64, Market Capitalization: $20.1 billion), a global medtech leader, reported steady 4Q23 results, with a...

HbA1c is less reliable in patients with CKD. A study found that glycated albumin associates with important long-term clinical outcomes in a non-dialysis CKD population.

HbA1c is less reliable in patients with CKD. A study found that glycated albumin associates with important long-term clinical outcomes in a non-dialysis CKD population.

The 72-week open-label extension of the phase 2b ORIGIN trial reveals atacicept's potential as a disease-modifying treatment for IgA nephropathy, showing eGFR stabilization and improvements in key indicators

Denmark: A recent study revealed that elevated albumin in the urine may be linked with sub-clinical coronary artery pathology, including coronary artery microcalcifications in individuals with type 2...

Investigators compared myeloperoxidase and PR3 ANCA-associated vasculitis. Renal prognoses differed between patients with the myeloperoxidase and PR3 ANCA-associated vasculitis type.